Assessment of iron deficiency anemia management in the general hospital of Grenoble: A 12-month follow-up of an intravenous ferric carboxymaltose treatment program in a cohort of patients with non-dialysis-dependent chronic kidney disease

Néphrologie & thérapeutique
Thierry RomanetPhilippe Zaoui

Abstract

The FIND-CKD study has validated the use of ferric carboxymaltose (FCM) injection with a target of ferritin level between 400 and 600ng/mL to treat iron deficiency anemia in non-dialysis-dependent chronic kidney disease (ND-CKD) patients. In order to assess this strategy in clinical practice, we constituted a cohort of patients within our nephrology department. Patients had CKD stages 3 to 5, hemoglobin level (Hb)<13g/dL (men) or<12g/dL (women), and ferritin level (F)<100ng/mL or transferrin saturation (TSAT)<20%. They were not treated by erythropoiesis-stimulating agent (ESA) for at least one month, and oral iron had been poorly tolerated or ineffective. FCM first dose was adjusted according to patient weight. A new infusion was possible, at least one month after the first, with a half-dose if TSAT<20% but F≥200ng/mL; no perfusion was performed if F≥400ng/mL. In all, 53 patients were included with a mean Hb of 11.4g/dL and a mean TSAT of 16%. Over one year of follow-up, only 12 patients (22.6%) needed another treatment for anemia (blood transfusion or ESA). No patient showed a significant decrease in Hb. In all, 62% of patients received only one infusion of FCM. The administration of FCM IV with ferritin levels in the recommen...Continue Reading

References

Sep 8, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gabriel MircescuNicolae Ursea
Nov 7, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Steven FishbaneMarshall M Joffe
Nov 3, 2009·The New England Journal of Medicine·Marc A PfefferUNKNOWN TREAT Investigators
Jan 19, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Simona StancuGabriel Mircescu
Apr 16, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesco LocatelliUNKNOWN ERA-EDTA ERBP Advisory Board
Mar 4, 2014·PloS One·Lucile MercadalUNKNOWN NephroTest Study Group
Jun 4, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Iain C MacdougallUNKNOWN FIND-CKD Study Investigators
Feb 17, 2015·European Journal of Heart Failure·Piotr PonikowskiUNKNOWN FAIR-HF Trial Investigators
Jun 18, 2015·Kidney International·Rajiv AgarwalMaria K Pappas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Iain C MacdougallFIND-CKD Study Investigators
Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Roberto MinutoloLuca De Nicola
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Iain C MacdougallFIND-CKD Study Investigators
© 2022 Meta ULC. All rights reserved